drugset / Trial / NCT00307749
Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary objectives of the study are to evaluate the efficacy and safety of three doses of MCC-257 in patients with mild to moderate diabetic polyneuropathy
Timeline
- Start
- 2006-03
- Primary completion
- —
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | COLENEURAMIDE | Small molecule | 20 mg | — |
| Subject | COLENEURAMIDE | Small molecule | 40 mg | — |
| Subject | COLENEURAMIDE | Small molecule | 80 mg | — |